| Target- | 
| MechanismVitamin K antagonists | 
|  | 
|  | 
|  | 
| Inactive Indication- | 
| Drug Highest PhaseApproved | 
| First Approval Ctry. / Loc.United States | 
| First Approval Date31 Jul 1944 | 
The effect of Sedodex® on ventilation efficacy in patients undergoing one lung ventilation during thracic surgery
100 Clinical Results associated with Imagen Biotech, Inc.
0  Patents (Medical) associated with Imagen Biotech, Inc.
100 Deals associated with Imagen Biotech, Inc.
100 Translational Medicine associated with Imagen Biotech, Inc.